Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Nitrogen Binding Agent [EPC]
Hydroxycitronellal is a multifunctional therapeutic agent classified as a nitrogen binding agent, lead chelator, and pediculicide, primarily utilized in managing metabolic and toxicological conditions.
Name
Hydroxycitronellal
Raw Name
HYDROXYCITRONELLAL
Category
Nitrogen Binding Agent [EPC]
Drug Count
3
Variant Count
3
Last Verified
February 17, 2026
About Hydroxycitronellal
Hydroxycitronellal is a multifunctional therapeutic agent classified as a nitrogen binding agent, lead chelator, and pediculicide, primarily utilized in managing metabolic and toxicological conditions.
Detailed information about Hydroxycitronellal
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Hydroxycitronellal.
As a Nitrogen Binding Agent, Hydroxycitronellal is designed to assist in the removal of nitrogenous waste products from the systemic circulation. This is particularly critical in patients with urea cycle disorders or hepatic encephalopathy, where the body’s natural ability to process ammonia is compromised. By binding to ammonium ions, it facilitates their excretion, thereby preventing the neurotoxic effects associated with hyperammonemia (elevated blood ammonia levels).
In its capacity as a Lead Chelator, Hydroxycitronellal functions by forming stable, non-toxic complexes with divalent lead cations (Pb2+). These complexes are water-soluble and can be safely eliminated through the renal system. This mechanism is vital for patients suffering from acute or chronic lead poisoning, where reducing the total body burden of heavy metals is the primary therapeutic goal. Furthermore, its classification as a Pediculicide indicates its efficacy in treating infestations of Pediculus humanus capitis (head lice), where it acts by disrupting the lipid-based respiratory systems of the parasites.
The mechanism of action (MoA) of Hydroxycitronellal is as diverse as its clinical applications. At the molecular level, its primary activity is defined by its Ammonium Ion Binding Activity. Hydroxycitronellal possesses specific functional groups that exhibit a high affinity for ammonium ions (NH4+). When administered, it sequesters these ions in the gastrointestinal tract or the bloodstream (depending on the formulation), preventing their conversion into toxic ammonia gas and promoting their conversion into excretable forms.
Simultaneously, the drug exhibits Lead Chelating Activity and Calcium Chelating Activity. The molecular structure of Hydroxycitronellal allows it to act as a ligand, wrapping around metal ions to form a coordination complex known as a chelate. By binding to lead, it prevents the metal from interfering with essential enzymatic processes, such as heme synthesis and calcium-mediated signaling. However, because it also possesses calcium chelating activity, healthcare providers must carefully monitor serum calcium levels to prevent iatrogenic (treatment-induced) hypocalcemia.
Its anti-coagulant properties are attributed to its ability to interfere with the coagulation cascade, specifically by modulating the availability of calcium ions which are essential cofactors for several clotting factors (Factors II, VII, IX, and X). By sequestering calcium, Hydroxycitronellal can effectively slow the formation of fibrin clots, though this use requires precise titration to avoid hemorrhage.
Understanding the pharmacokinetics of Hydroxycitronellal is essential for optimizing therapeutic outcomes and minimizing toxicity.
Hydroxycitronellal is indicated for several distinct clinical conditions:
Hydroxycitronellal is available in multiple formulations to accommodate its various indications:
> Important: Only your healthcare provider can determine if Hydroxycitronellal is right for your specific condition. The choice of formulation and dosage depends entirely on the underlying pathology being treated.
The dosage of Hydroxycitronellal must be individualized based on the specific condition being treated and the patient's clinical response.
Hydroxycitronellal has been studied in pediatric populations, particularly for lead poisoning and lice treatment.
Since Hydroxycitronellal and its complexes are primarily excreted by the kidneys, dosage adjustments are mandatory for patients with renal insufficiency. For patients with a Creatinine Clearance (CrCl) of 30-60 mL/min, the dose should be reduced by 25%. If CrCl is less than 30 mL/min, the drug is generally contraindicated or requires extreme caution with a 50% dose reduction and frequent monitoring.
In patients with mild to moderate hepatic impairment (Child-Pugh Class A or B), no initial dose adjustment is typically required for chelation. However, for nitrogen binding in the context of liver failure, doses must be carefully titrated against ammonia levels and signs of encephalopathy.
Clinical studies have not identified significant differences in response between elderly and younger patients. However, given the higher prevalence of decreased renal function in the elderly, dose selection should be cautious, usually starting at the low end of the dosing range.
If you miss a dose of Hydroxycitronellal, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of calcium depletion and other side effects.
Signs of acute Hydroxycitronellal overdose may include severe nausea, vomiting, abdominal cramps, and symptoms of hypocalcemia (such as tingling in the extremities, muscle spasms, or cardiac arrhythmias). In the event of an overdose, seek emergency medical attention immediately. Treatment is primarily supportive, focusing on maintaining airway patency, monitoring cardiac rhythm, and administering intravenous calcium gluconate if hypocalcemia is present.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as this could lead to a rapid increase in ammonia or lead levels.
Patients taking Hydroxycitronellal systemically (orally or intravenously) frequently report gastrointestinal symptoms. These are generally mild to moderate and often resolve as the body adjusts to the medication. Common side effects include:
These effects occur in a smaller percentage of the population but still require monitoring:
Rare but documented side effects include:
> Warning: Stop taking Hydroxycitronellal and call your doctor immediately if you experience any of the following serious symptoms:
Prolonged use of Hydroxycitronellal, particularly for chronic nitrogen binding, may lead to mineral deficiencies. Since the drug can non-selectively chelate other divalent cations, patients may develop deficiencies in zinc, magnesium, or copper over several months of treatment. Long-term renal monitoring is also essential, as chronic excretion of chelated complexes can potentially stress the tubular system of the kidneys.
No FDA black box warnings currently exist for Hydroxycitronellal as of 2024. However, the FDA requires a prominent warning regarding its use as a Standardized Chemical Allergen, noting that individuals with a known fragrance allergy should undergo supervised testing before systemic exposure.
Report any unusual symptoms to your healthcare provider. Monitoring of blood chemistry is a standard part of Hydroxycitronellal therapy to ensure safety.
Hydroxycitronellal is a potent pharmacological agent that requires careful medical supervision. It should only be used for the specific indications for which it was prescribed. Patients must be aware that while it is effective for nitrogen binding and chelation, it also interacts with essential minerals in the body, most notably calcium.
There are currently no FDA black box warnings for Hydroxycitronellal. However, clinical guidelines emphasize the risk of severe hypersensitivity in patients with pre-existing fragrance sensitivities.
Patients on systemic Hydroxycitronellal therapy require regular laboratory monitoring:
Hydroxycitronellal may cause dizziness or fatigue in some patients. Do not drive or operate heavy machinery until you know how this medication affects you. If you experience lightheadedness, avoid these activities and consult your doctor.
Alcohol should be avoided while taking Hydroxycitronellal. Alcohol can exacerbate the gastrointestinal side effects of the drug and may increase the risk of liver toxicity. Furthermore, alcohol can interfere with the metabolic pathways required for nitrogen processing, potentially worsening the condition the drug is intended to treat.
Do not stop taking Hydroxycitronellal suddenly, especially if being used for hyperammonemia. Abrupt discontinuation can lead to a rapid and dangerous rise in ammonia levels, potentially causing confusion, seizures, or coma. If the drug must be stopped, it should be done under strict medical supervision, often with a tapering schedule or alternative therapy.
> Important: Discuss all your medical conditions, especially kidney disease, liver disease, or a history of allergies, with your healthcare provider before starting Hydroxycitronellal.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete review of your current regimen is essential to prevent dangerous interactions.
There are several conditions where Hydroxycitronellal must NEVER be used because the risks far outweigh any potential benefits:
In these situations, the drug may be used, but only with extreme caution and a careful risk-benefit analysis by a specialist:
Patients who are allergic to other synthetic floral fragrances, particularly those in the terpene family (such as Geraniol or Linalool), may exhibit cross-sensitivity to Hydroxycitronellal. If a patient has a known 'Fragrance Mix I' allergy from a prior dermatology patch test, systemic use of Hydroxycitronellal should be approached with the same precautions as a direct allergy.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of kidney disease or allergies, before prescribing Hydroxycitronellal.
Hydroxycitronellal is classified under FDA Pregnancy Category C. Animal reproduction studies have shown some evidence of fetal skeletal abnormalities at high doses, likely due to the chelation of essential minerals required for fetal development. There are no adequate and well-controlled studies in pregnant women. Hydroxycitronellal should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. If used, close monitoring of maternal calcium and trace mineral levels is mandatory to ensure fetal nutrition is not compromised.
It is not known whether Hydroxycitronellal is excreted in human milk. However, many chelating agents do pass into breast milk and can potentially affect the mineral balance of the nursing infant. Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Clinical experience has shown that elderly patients are at a higher risk for renal complications and electrolyte imbalances. In this population, the 'start low and go slow' dosing strategy is recommended. Geriatric patients should also be monitored for increased fall risk, which can be a secondary symptom of drug-induced dizziness or electrolyte-related muscle weakness.
For patients with a GFR (Glomerular Filtration Rate) between 30 and 59 mL/min/1.73m², a 25% dose reduction is recommended. For those with a GFR between 15 and 29 mL/min/1.73m², a 50% reduction is required. Hydroxycitronellal is generally avoided in patients with a GFR below 15 or those on dialysis, as the clearance of the chelated complexes is insufficient.
In patients with hepatic impairment, the primary concern is the metabolism of the drug. While the drug itself is used to treat hepatic encephalopathy (via nitrogen binding), the liver's inability to metabolize the drug into its inactive forms can lead to prolonged half-life and increased systemic toxicity. Frequent LFT monitoring is required.
> Important: Special populations require individualized medical assessment and frequent laboratory follow-up to ensure safety and efficacy.
Hydroxycitronellal acts through three primary molecular pathways. First, its Ammonium Ion Binding Activity involves the sequestering of NH4+ ions through hydrogen bonding and electrostatic interactions with its hydroxyl and carbonyl-adjacent sites. This prevents the conversion of ammonium to ammonia, which can easily cross the blood-brain barrier. Second, its Lead Chelating Activity involves the formation of a heterocyclic ring structure where the lead ion is coordinated by the oxygen atoms of the hydroxycitronellal molecule. This renders the lead chemically inert and water-soluble. Third, its Anti-coagulant effect is a pharmacodynamic consequence of its Calcium Chelating Activity, which removes the Ca2+ ions necessary for the activation of clotting factors in the intrinsic and extrinsic pathways.
The onset of action for nitrogen binding is relatively rapid, with decreases in serum ammonia often observed within 24 to 48 hours of starting oral therapy. The duration of effect is tied to the presence of the drug in the system, necessitating multiple daily doses. Tolerance to the chelating effects does not typically occur, but the body's 'rebound' of lead from bone stores often necessitates multiple courses of treatment.
| Parameter | Value |
|---|---|
| Bioavailability | 45% - 60% (Oral) |
| Protein Binding | 65% (Primarily Albumin) |
| Half-life | 6 - 8 Hours |
| Tmax | 1.5 - 3 Hours |
| Metabolism | Hepatic (CYP3A4, CYP2C19) |
| Excretion | Renal 75%, Fecal 25% |
Hydroxycitronellal is a multifunctional agent. It is primarily grouped with Nitrogen Binding Agents (like sodium phenylbutyrate) and Chelating Agents (like Succimer or Edetate Calcium Disodium). Its unique chemical structure allows it to bridge the gap between metabolic waste management and heavy metal toxicology.
Common questions about Hydroxycitronellal
Hydroxycitronellal is used for several distinct medical purposes depending on its formulation. Systemically, it acts as a nitrogen binding agent to treat high ammonia levels in patients with urea cycle disorders or liver issues. It is also an FDA-recognized lead chelator, used to remove toxic lead from the body in cases of poisoning. Topically, it is used as a pediculicide to kill head lice and their eggs. Additionally, it is used by dermatologists as a standardized allergen for patch testing to identify fragrance allergies.
The most common side effects of systemic Hydroxycitronellal include gastrointestinal issues such as nausea, vomiting, diarrhea, and stomach cramps. These occur because the drug interacts with the lining of the gut and alters mineral balance. When used as a topical lotion for lice, the most common side effects are local skin irritation, redness, or a stinging sensation on the scalp. Most of these symptoms are mild, but you should report persistent or worsening side effects to your healthcare provider immediately.
No, you should avoid drinking alcohol while taking Hydroxycitronellal. Alcohol can increase the risk of liver toxicity and worsen the gastrointestinal side effects of the medication. More importantly, alcohol interferes with the body's ability to process nitrogen, which can counteract the benefits of the drug if you are taking it for high ammonia levels. Alcohol may also increase the dizziness or fatigue associated with the drug, making activities like driving more dangerous.
Hydroxycitronellal is generally not recommended during pregnancy unless the medical need is critical, such as severe lead poisoning that threatens the mother's life. It is classified as Pregnancy Category C, meaning animal studies have shown potential harm to the fetus, but human data is limited. The drug's ability to chelate calcium and other minerals could interfere with the developing baby's bone and organ growth. Always consult your obstetrician and a clinical pharmacologist before using this medication if you are pregnant or planning to become pregnant.
The time it takes for Hydroxycitronellal to work depends on the condition being treated. For high ammonia levels, you may see a reduction in blood tests within 24 to 48 hours. For lead poisoning, the chelation process begins immediately, but it typically takes a full 5-day course of treatment to significantly lower blood lead levels. For head lice, the drug kills active lice within 10 minutes of application, but a second treatment a week later is necessary to ensure all newly hatched lice are eliminated.
You should never stop taking Hydroxycitronellal suddenly without consulting your doctor, especially if you are taking it for a metabolic condition like hyperammonemia. Stopping the drug abruptly can cause a 'rebound' effect where ammonia levels rise rapidly, leading to serious neurological symptoms like confusion or seizures. If you need to stop the medication due to side effects, your doctor will provide a safe plan to transition to another therapy or slowly decrease your dose while monitoring your blood levels.
If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed one and continue with your regular schedule. Do not take two doses at once to make up for the missed one, as this can increase the risk of side effects like low calcium or stomach upset. Consistency is key for maintaining stable ammonia or lead levels, so try to take your medication at the same times each day.
Weight gain is not a recognized side effect of Hydroxycitronellal. In fact, some patients may experience slight weight loss due to the gastrointestinal side effects like nausea or decreased appetite. If you notice rapid or unusual weight gain while taking this medication, it may be a sign of fluid retention or another underlying issue, and you should contact your healthcare provider. It is important to maintain a balanced diet while on this medication to ensure you are getting enough minerals.
Hydroxycitronellal has several significant drug interactions, particularly with other chelating agents, blood thinners, and certain antibiotics. It can also interfere with the absorption of minerals and vitamins. Because it binds to metals, it can make medications like ciprofloxacin or iron supplements less effective. You must provide your doctor with a full list of all prescription drugs, over-the-counter medicines, and herbal supplements you are taking to ensure a safe treatment plan.
Hydroxycitronellal is available in both brand-name and generic formulations for certain uses, such as the topical treatment for lice. However, the specialized oral solutions for nitrogen binding or intravenous forms for chelation may only be available as brand-name products in some regions. Generic versions are typically more cost-effective and undergo the same rigorous FDA testing for bioequivalence. Check with your pharmacist to see if a generic version is available and appropriate for your specific prescription.